| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |